Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells

Oncogene. 2004 Mar 4;23(9):1704-11. doi: 10.1038/sj.onc.1207289.

Abstract

Histone deacetylase (HDAC) plays a key role in gene expression, by suppressing the transcription of a number of target genes. Identification of such genes is important for deciphering the functional role of HDAC. Here, using cancer gene-focused DNA microarray analysis, we identified plakoglobin as a new target gene of HDAC. Functional inhibition of HDAC by its specific inhibitors induced the expression of plakoglobin by eight-fold in human fibrosarcoma HT1080 cells. However, the expression of beta-catenin, which is closely related to plakoglobin, was not altered, implying the specific function of HDAC in plakoglobin expression. Using antiacetyl-H4 antibody, chromatin immunoprecipitation analysis revealed that the distal region (-945 approximately -646) of the promoter of plakoglobin is responsible for the HDAC-mediated repression of the gene. Moreover, the induced expression of plakoglobin by the inhibition of HDAC activated the Tcf/Lef-dependent luciferase reporter gene, a well-known downstream effector of the Wnt signaling pathway. Furthermore, transient transfection of plakoglobin also activated Tcf/Lef reporter gene expression. Taken together, our results demonstrate that plakoglobin is a new target gene governed by HDAC, and that it acts as an oncogene in HT1080 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology
  • Cell Line, Tumor
  • Chromatin / drug effects
  • Chromatin / genetics
  • Chromatin / metabolism
  • Chromatin Assembly and Disassembly / drug effects
  • Cytoskeletal Proteins / genetics*
  • Cytoskeletal Proteins / metabolism
  • DNA-Binding Proteins / genetics
  • Decitabine
  • Desmoplakins
  • Enzyme Inhibitors / pharmacology
  • Fibrosarcoma / genetics*
  • Fibrosarcoma / metabolism
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Genes, Reporter / genetics
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases / metabolism*
  • Humans
  • Hydroxamic Acids / pharmacology
  • Lymphoid Enhancer-Binding Factor 1
  • Oligonucleotide Array Sequence Analysis
  • Promoter Regions, Genetic / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Trans-Activators / genetics
  • Transcription Factors / genetics
  • Transcriptional Activation / drug effects
  • beta Catenin
  • gamma Catenin

Substances

  • CTNNB1 protein, human
  • Chromatin
  • Cytoskeletal Proteins
  • DNA-Binding Proteins
  • Desmoplakins
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Lymphoid Enhancer-Binding Factor 1
  • RNA, Messenger
  • Trans-Activators
  • Transcription Factors
  • beta Catenin
  • gamma Catenin
  • trichostatin A
  • Decitabine
  • Histone Deacetylases
  • Azacitidine